πŸ‡ΊπŸ‡Έ FDA
Patent

US 10584147

Procoagulant fusion compound

granted A61KA61K38/00

Quick answer

US patent 10584147 (Procoagulant fusion compound) held by BIOVERATIV THERAPEUTICS INC. expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOVERATIV THERAPEUTICS INC.
Grant date
Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/00